Headache Relief
- Product NDC
- 55910-686
- 11-digit product format
- 559100686
- Labeler code
- 55910
- Product ID
- 55910-686_875ec027-a639-4f41-a064-971eb1a8b123
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin, Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-03-31
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Headache Relief
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308297 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5ffcc78d-9163-4cb4-8811-ae9f0142806a | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55910-686-20 | 2020-08-26 | C162847 | 48780-1 | ab0e2407-369d-f274-e053-dbdaa90a6471 | Drug Facts |
| 55910-686-20 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-369d-f274-e053-dbdaa90a6471 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55910-686-20 | Headache ReliefExtra Strength | 1 in 1 BOX | TABLET | 1 | 5 | |
| 55910-686-20 | Headache ReliefExtra Strength | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55910-686 | HEADACHE RELIEF EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240319_5ffcc78d-9163-4cb4-8811-ae9f0142806a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PANADOL Extra | ACETAMINOPHEN AND CAFFEINE | Haleon US Holdings LLC | e5c2d88a-d903-4ca0-b895-f27e791dfc4e | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | b2fe7f47-1a2e-40ee-8f8f-38f2028dce1b | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | 9d384e88-5c11-4600-ac6c-a38371570138 | 2024-02-06 | Warnings | M013 |
| PANADOL | ACETAMINOPHEN | Haleon US Holdings LLC | 95801755-db54-4ad7-bec1-52671914f6ca | 2024-02-06 | Warnings | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | 01e7dddb-755c-4745-b701-edcdb6209064 | 2024-02-06 | Warnings, Adverse reactions | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | fe7cd1f2-9b00-4ded-99c2-8a152c71093c | 2024-02-06 | Warnings, Adverse reactions | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 9064943f-836f-4853-b6f2-2c4879941eeb | 2024-02-02 | Warnings | M013 |
| Quality Choice Effervescent Pain Relief | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 079af5d7-1be8-2a93-e063-6294a90a496d | 2024-02-01 | Warnings | M013 |
| MEDI-FIRST Non-Aspirin | ACETAMINOPHEN | Proficient Rx LP | 4c84948d-3a95-4c53-8529-7e7b9d8bb6df | 2024-02-01 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN | Proficient Rx LP | 9c7d65e4-df2f-47c1-a185-66aaf19aad2b | 2024-02-01 | Warnings | M013 |
| Childrens Acetaminophen | ACETAMINOPHEN | Proficient Rx LP | 57e4820c-b4eb-442e-9c49-93eedfbc5e5e | 2024-02-01 | Warnings | M013 |
| good sense aspirin | ASPIRIN | Proficient Rx LP | 73013074-9c6e-43c7-acde-4d9d8ed0133d | 2024-02-01 | Warnings | M013 |
| MEDIQUE APAP Extra Strength | ACETAMINOPHEN | Proficient Rx LP | c466a07f-2339-4cf5-8377-e0f109649c52 | 2024-02-01 | Warnings | M013 |
| Percogesic Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE | Medtech Products Inc. | 2c5f1140-fb83-42c9-b0b1-5e2bd69340bb | 2024-02-01 | Warnings | M013 |
| aspirin | ASPIRIN | Proficient Rx LP | 3c7783a7-2b28-4968-b766-0a49dc70ce6d | 2024-02-01 | Warnings | M013 |
| Regular Strength Pain Relief | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 102bdcde-cb90-f248-e063-6394a90aac79 | 2024-01-30 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Haleon US Holdings LLC | 61802b27-c9ec-4386-9d44-45e8b1e558b7 | 2024-01-28 | Warnings | M013 |
| AGRIFEN | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | 0fde22da-cdfc-36cc-e063-6294a90a3885 | 2024-01-26 | Warnings | M013 |
| DOLODOL | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | e80536f1-92cc-5bb3-e053-2995a90a9540 | 2024-01-26 | Warnings | M013 |
| LOW DOSE ASPIRIN | ASPIRIN | Bryant Ranch Prepack | d913d11f-c7a1-49d2-a2d3-9a29fc032806 | 2024-01-18 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 5ffcc78d-9163-4cb4-8811-ae9f0142806a | 5 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 5ffcc78d-9163-4cb4-8811-ae9f0142806a | 5 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 5ffcc78d-9163-4cb4-8811-ae9f0142806a | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55910-686-20 | 55910068620 | 1 BOTTLE, PLASTIC in 1 BOX (55910-686-20) / 20 TABLET in 1 BOTTLE, PLASTIC | 2019-03-31 | 0000-00-00 | No | No | Current |